A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops - Trial NCT06209281
Access comprehensive clinical trial information for NCT06209281 through Pure Global AI's free database. This Phase 3 trial is sponsored by Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. and is currently Recruitment Completed. The study focuses on Myopia. Target enrollment is 526 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Timeline & Enrollment
Phase 3
May 13, 2022
Aug 01, 2024
Primary Outcome
Cycloplegic Autorefraction(low)
Summary
This study was a randomized, double-blind, placebo-controlled, multicenter, superiority
 design, phase III clinical trial to compare the efficacy and safety of two low-concentration
 atropine sulfate eye drops versus placebo in delaying myopia progression in children.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06209281
Non-Device Trial